Neuroendocrine Tumors of Stomach
Primary Site | Histology | Staging Type |
---|---|---|
C160-C166, C168-C169 | 8153, 8240-8242, 8246, 8249 | TNM 7 and Summary Stage |
If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual
Notes
C160 Cardia of stomach C161 Fundus of stomach C162 Body of stomach C163 Gastric antrum C164 Pylorus C165 Lesser curvature of stomach, NOS C166 Greater curvature of stomach, NOS C168 Overlapping lesion of stomach C169 Stomach, NOS **Note 1:** This schema is based on the UICC chapter *Gastric, Small & Large Intestinal Carcinoid Tumours,* pages 94-99. **Note 2:** For this schema, TNM only stages well-differentiated neuroendocrine tumors. Note that the "concept" of well-differentiated is reflected in the histology code. The grade code is not needed in order to select the correct schema, but does need to be coded. **Note 3:** In addition to directly assigning TNM, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Stomach* chapter on page 80 of the [SS2000 on-line manual](http://seer.cancer.gov/tools/ssm/SSSM2000-122012.pdf#page=80).Main Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Clinical T | <BLANK> | Yes | NAACCR #940 | None | |
Clinical N | <BLANK> | Yes | NAACCR #950 | None | |
Clinical M | <BLANK> | Yes | NAACCR #960 | None | |
TNM Clin Stage Group | 99 | Yes | NAACCR #970 | None | |
Pathologic T | <BLANK> | Yes | NAACCR #880 | None | |
Pathologic N | <BLANK> | Yes | NAACCR #890 | None | |
Pathologic M | <BLANK> | Yes | NAACCR #900 | None | |
TNM Path Stage Group | 99 | Yes | NAACCR #910 | None | |
SSF6: Mitotic Count | 988 | No | NAACCR #2930 | None | None |
SSF11: Serum Chromogranin A (CgA) Lab Value | 988 | No | NAACCR #2865 | CCCR/Canada COC |
None |
SSF12: Urinary 5-HIAA Lab Value | 988 | No | NAACCR #2866 | CCCR/Canada COC |
None |
Additional Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | No | NAACCR #390 | None | |
Primary Site | <BLANK> | Yes | NAACCR #400 | None | |
Histology | <BLANK> | Yes | NAACCR #522 | None | |
Behavior | <BLANK> | Yes | NAACCR #523 | None | |
RX Summ Systemic/Surgery Sequence | <BLANK> | Yes | NAACCR #1639 | None | |
RX Summ Surgery/Radiation Sequence | <BLANK> | Yes | NAACCR #1380 | None | |
Regional Nodes Positive | <BLANK> | Yes | NAACCR #820 | None |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item |
---|---|---|---|
Derived Version | {{ctx_alg_version}} | None | |
Derived SEER Clin Stage Group | 88 | NAACCR #3610 | |
Derived SEER Path Stage Group | 88 | NAACCR #3605 | |
Derived SEER Combined Stage Group | 88 | NAACCR #3614 | |
Derived SEER Combined T | 88 | NAACCR #3616 | |
Derived SEER Combined N | 88 | NAACCR #3618 | |
Derived SEER Combined M | 88 | NAACCR #3620 | |
Derived SEER Combined T Source | <BLANK> | NAACCR #3622 | |
Derived SEER Combined N Source | <BLANK> | NAACCR #3624 | |
Derived SEER Combined M Source | <BLANK> | NAACCR #3626 |